System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Live1m

Terminal Asset View

stockNASDAQ

IDYA

$33.09+0.79%

Ideaya Biosciences Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

45Neutral

Live Analysis Active

Company Mission

It creates targeted cancer drugs that attack specific genetic mutations in tumors, helping patients with fewer side effects. Doctors and hospitals use these therapies for personalized treatment plans. The company makes money through research partnerships, licensing deals, and future sales of approved drugs.

IDY

Industry Context

This company operates in the biotechnology sector, focusing on precision medicine for cancer treatment. It develops therapies that target specific genetic mutations in tumors, aiming to improve patient outcomes with fewer side effects. The industry is growing due to advances in genomics and increased investment in personalized healthcare.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

59Matrix

Market Momentum

49.2— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

0.79%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing IDYA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 02:57 AM UTC

As-of As of 2026-03-16T02:41:54.271Z UTC (~15m delay).

Develops targeted cancer therapies by focusing on specific genetic mutations, earning revenue through partnerships and potential drug sales.

Weekly range is narrowing near $20, often a precursor to a significant breakout or breakdown. Watch for price breaking above or below this level.

Volume spiked 2x at $20, indicating institutional interest because it aligns with key technical levels. Monitor if volume stays above average.

Industry trend toward precision medicine is driving strength, with price holding above $33, signaling bullish outlook. Watch for sector momentum in biotech.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...